Results 81 to 90 of about 15,810 (189)

A Rare Case of Prosthetic Joint Infection Caused by Group D Salmonella

open access: yesCase Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
Prosthetic joint infections (PJIs) are gaining growing attention as a healthcare issue. Salmonella spp. is a rare cause of PJI, mostly involving hip arthroplasty rather than knee arthroplasty. Therefore, clinical experience on the management of PJI involving knee arthroplasties caused by Salmonella spp. is scant.
Anna Barbiero   +8 more
wiley   +1 more source

In Vitro Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa

open access: yes, 2017
Guidelines for the treatment of sepsis, febrile neutropenia, and hospital-acquired pneumonia caused by Pseudomonas aeruginosa include empirical regimens incorporating two antibiotics from different classes with activity against
Kellie J. Goodlet   +2 more
core   +1 more source

Global evaluation of the antibacterial activity of Ceftolozane/Tazobactam against ESBLs-producing and : a systematic review and meta-analysis

open access: yesTherapeutic Advances in Infectious Disease, 2023
Background: Ceftolozane/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a high range of efficacy and broad-spectrum action against multidrug-resistant bacterial strains. Objectives: The present study aimed to analyze the in vitro activity
Marzieh Rahim Khorasani   +3 more
doaj   +1 more source

Relapsing Salmonella Meningitis in an Infant: A Case Report and Review of the Literature

open access: yesCase Reports in Pediatrics, Volume 2026, Issue 1, 2026.
Accurate diagnosis of bacterial meningitis is critical, particularly in young febrile infants. Although commercially available multiplex PCR assays enable rapid pathogen detection, these typically do not include Salmonella spp. or other Enterobacteriaceae, which may result in missed diagnoses and/or inappropriate treatment duration.
Sonia Alexiadou   +7 more
wiley   +1 more source

When the Medium Skews the Message: Commercial Mueller–Hinton Agar Media and Their Effect on Antibiogram Results of Imipenem, Ciprofloxacin, and Gentamicin Against Standard and Clinical Strains of Pseudomonas aeruginosa

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
Accurate antimicrobial susceptibility testing (AST) is essential for guiding effective therapy and monitoring antibiotic resistance, particularly for Pseudomonas aeruginosa, a pathogen noted for its intrinsic and adaptive resistance mechanisms. Mueller–Hinton agar (MHA) is the standard medium for AST; however, variations in its composition among ...
Amir Reza Abdollahi   +6 more
wiley   +1 more source

Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam

open access: yes, 2017
Ceftolozane/tazobactam is a novel fifth-generation cephalosporin β-lactamase combination with activity against extended-spectrum β-lactamases-producing enterobacteriaceae, and multidrug resistant Pseudomonas aeruginosa.
Marta Bodro   +4 more
core   +1 more source

Ceftolozane/tazobactam: Novelantipseudomonal cephalosporin [PDF]

open access: yesPharmacy Today, 2015
Abstract Another much-needed antibiotic enters the marketplace with FDA'sapproval of ceftolozane/tazobactam (Zerbaxa—Cubist) for the treatmentof adult patients with complicated intra-abdominal infections(cIAI) in combination with metronidazole and for complicated urinarytract infections (cUTI), including pyelonephritis.
openaire   +1 more source

Molecular Characterization and Antibiotic Resistance of Broad‐Spectrum β‐Lactamase‐Producing Enterobacterales in Urinary Tract Infections in Libreville, Gabon

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
Background The effectiveness of antibiotic therapy for urogenital tract infections (UTIs) is increasingly compromised by the global dissemination of extended‐spectrum β‐lactamase‐producing Enterobacterales (ESβL‐En). This study aimed to assess the involvement of broad‐spectrum β‐lactamase‐producing Enterobacterales (BSβL‐En) in UTIs and to establish ...
Jean Fabrice Yala   +7 more
wiley   +1 more source

A Review of β‐Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
β‐Lactam antibiotics have long served as a cornerstone for treating bacterial infections. However, their widespread and often indiscriminate use has fueled the emergence of multidrug‐resistant Gram‐negative pathogens, primarily through the production and dissemination of β‐lactamase enzymes.
Mohammad Javad Roustaye Gourabi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy